Q1 FinancialsI believe our Q1 was announced around the end of March last year.. We should be gearing up pretty soon for Q1 2021. I'm wondering if we will get some further funding from Baxter this go around? If memory serves Tigris was supposed to be wrapping up OCT 2021... I'm sure with cv19 there will be some grace given, unless of course the efficacy of the data supports what was already proven in the Euphrates Trial and we can finally get the proverbial show on the road. I've become accustomed to management keeping overtly tight lipped about their future plans, however it seems that we should get some news shortly as to their plan to roll out Dialco and/or list on a major US exchange. My only issue with the US listing is that it doesn't really play into the buyout theory... If a deal has already been shook upon i don't see them jumping through all those hoops to get US exposure to.drive share price if they haven't done anything in the last four + years to get this story out there. In the famous words of William Blake "What is now proved, was once imagined" i think this ties in nicely with our little diamond in the rough... Regards.